EP 2089050 A2 20090819 - IL- 17B FOR USE IN WOUND HEALING
Title (en)
IL- 17B FOR USE IN WOUND HEALING
Title (de)
IL-17B ZUR ANWENDUNG IN DER WUNDHEILUNG
Title (fr)
UTILISATION DE L'IL-17B POUR LA CICATRISATION DES PLAIES
Publication
Application
Priority
- US 2007084151 W 20071108
- US 86486706 P 20061108
Abstract (en)
[origin: WO2008073653A2] IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tissue. When IL-17B is absent a marked negative effect on wound healing is noted. The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing process. The present invention further encompasses a pharmaceutical composition and formulations thereof that utilize IL-17B, either alone or in combination with other cytokines or growth factors known to aid wound healing. The invention also contemplates methods of treating wounds in patients using this pharmaceutical composition.
IPC 8 full level
A61K 38/20 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/21 (2006.01); A61K 38/30 (2006.01); A61P 17/02 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 38/18 (2013.01); A61K 38/19 (2013.01); A61K 38/20 (2013.01); A61K 38/30 (2013.01); A61P 17/02 (2017.12); A61P 17/06 (2017.12); Y02A 50/30 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 2008073653A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008073653 A2 20080619; WO 2008073653 A3 20080807; CA 2669109 A1 20080619; EP 2089050 A2 20090819; JP 2010509364 A 20100325
DOCDB simple family (application)
US 2007084151 W 20071108; CA 2669109 A 20071108; EP 07871415 A 20071108; JP 2009536488 A 20071108